Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Danaher Corp (NY: DHR )

276.43 +4.53 (+1.67%)
Official Closing Price Updated: 7:00 PM EDT, Sep 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Danaher Corp

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Momentum Investing Gives You An Edge, Until It Doesn’t
Since 2020, momentum investing has generated significantly better returns than other strategies. Such is not surprising, given the massive amounts of stimulus injected into the financial system. 
Via Talk Markets
Unpacking the Latest Options Trading Trends in Danaher
Via Benzinga
$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Smart Money Is Betting Big In DHR Options
Via Benzinga
Agilent Technologies Thrives From the Forever Chemicals Crackdown
Agilent Technologies Inc. (NYSE: A) is a diversified global leader in the life sciences, diagnostics and applied chemical markets. 
Via MarketBeat
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,200 Today
Via Benzinga
Behind the Scenes of Danaher's Latest Options Trends
Via Benzinga
$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
Via Benzinga
(DHR) - Analyzing Danaher's Short Interest
Via Benzinga
The Defensive Sectors And VIX Have NOT Given The All-Clear Signal
The market has been a rollercoaster lately, with the resilience of defensive sectors and the modest bounce in the technology sector painting an intriguing picture. 
Via Talk Markets
Topics Stocks
Exposures US Equities
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount'
Jim Cramer said Constellation Energy is a "solar play that is a very good company. It's up a huge amount versus a lot of other stocks." 
Via Benzinga
Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease
From Biogen Inc.
Via GlobeNewswire
Demystifying Danaher: Insights From 5 Analyst Reviews
Via Benzinga
Market Whales and Their Recent Bets on DHR Options
Via Benzinga
Universal Health Services & Lockheed Martin Were Among Top 11 Large Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
11 large-cap stocks saw significant gains in the last week, driven by positive earnings and guidance updates. Check if they're in your portfolio. 
Via Benzinga
Top Stock Reports For Costco, Danaher & ServiceNow
Today's Research Daily features new research reports on 16 major stocks, including Costco, Danaher Corporation and ServiceNow, as well as two micro-cap stocks AMREP Corporation and Autoscope... 
Via Talk Markets
It's Time for Some Enthusiasm for Small-Cap Stocks
After a year and a half of big names pushing the market forward, some smaller companies are starting to go on a run. 
Via The Motley Fool
$100 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
Via Benzinga
(DHR) - Analyzing Danaher's Short Interest
Via Benzinga
$100 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Key Takeaways From Danaher Analyst Ratings
Via Benzinga
Freeport-McMoRan, Pfizer, Danaher And An Industrial Stock: CNBC's 'Final Trades'
Freeport-McMoRan is Bryn Talkington's "final trade." On July 23, Freeport-McMoRan said second-quarter revenue came in at $6.62 billion. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Here's Why Danaher Stock Surged Today
The biotechnology, diagnostics, and life sciences company looks set to return to its long-term growth rate. 
Via The Motley Fool
Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
DHR Stock Earnings: Danaher Beats EPS, Beats Revenue for Q2 2024
DHR stock results show that Danaher beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Medical Giant Danaher Nears Breakout On This 'Stark Contrast' With A Key Rival
The company kept its outlook for the year, which differs from Sartorius' cut last week. 
Via Investor's Business Daily
Life Science Giant Danaher's Q2 Earnings Beat Estimates On 'Sustained Positive Momentum In Bioprocessing Business', Maintains Guidance
Danaher reported a 3% year-over-year decline in Q2 sales to $5.743 billion, surpassing the $5.59 billion consensus. Adjusted EPS was $1.72, beating expectations of $1.57. CEO Rainer Blair highlighted... 
Via Benzinga
Topics Earnings
Exposures Financial
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.